{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T03:35:35Z","timestamp":1648524935613},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.eimc.2013.04.002","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T04:47:41Z","timestamp":1370321261000},"page":"99.e1-99.e14","source":"Crossref","is-referenced-by-count":1,"title":["Documento de consenso sobre la asistencia en el \u00e1mbito sanitario a las mujeres con infecci\u00f3n por el virus de la inmunodeficiencia humana"],"prefix":"10.1016","volume":"32","member":"78","reference":[{"key":"10.1016\/j.eimc.2013.04.002_bib0005","unstructured":"Grupo de trabajo ONUSIDA\/OMS. Informe sobre la epidemia mundial de sida, 2012."},{"key":"10.1016\/j.eimc.2013.04.002_bib0010","unstructured":"Informe de vigilancia epidemiol\u00f3gica de VIH\/sida en Espa\u00f1a. Actualizaci\u00f3n a 30 de junio de 2012. Secretaria del Plan Nacional sobre el Sida."},{"key":"10.1016\/j.eimc.2013.04.002_bib0015","unstructured":"Vigilancia epidemiol\u00f3gica del VIH en Espa\u00f1a. Valoraci\u00f3n de los nuevos diagn\u00f3sticos de VIH en Espa\u00f1a a partir de los Sistemas de Notificaci\u00f3n de casos de las CC.AA. Periodo 2003-2011. Actualizaci\u00f3n 30 de junio de 2012. Ministerio de Econom\u00eda y Competitividad. Ministerio de Sanidad, Servicios Sociales e Igualdad. Secretar\u00eda del Plan Nacional sobre el Sida."},{"key":"10.1016\/j.eimc.2013.04.002_bib0020","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/QAD.0b013e3283390db3","article-title":"Better mind the gap: Addressing the shortage of HIV-positive women in clinical trials","volume":"24","author":"D\u2019Arminio Monfortea","year":"2010","journal-title":"AIDS"},{"issue":"Suppl 4","key":"10.1016\/j.eimc.2013.04.002_bib0025","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/01.aids.0000341772.48382.57","article-title":"Introduction: Addressing the vulnerability of young women and girls to stop the HIV epidemic in southern Africa","volume":"22","author":"Stirling","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.04.002_bib0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/QAI.0b013e31814d4dad","article-title":"Associations between recent gender-based violence and pregnancy, sexually transmitted infections, condom use practices, and negotiation of sexual practices among HIV-positive women","volume":"46","author":"Lang","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0035","series-title":"Sexos, g\u00e9nero y salud. Teor\u00eda y m\u00e9todos para la pr\u00e1ctica cl\u00ednica","author":"Velasco","year":"2009"},{"key":"10.1016\/j.eimc.2013.04.002_bib0040","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4067\/S0034-98872007000600004","article-title":"Perspectiva de g\u00e9nero en la formaci\u00f3n de los profesionales de la salud: una tarea pendiente","volume":"135","author":"Arcos","year":"2007","journal-title":"Rev Med Chile"},{"key":"10.1016\/j.eimc.2013.04.002_bib0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00126334-200012150-00006","article-title":"Physician-patient communication in HIV disease: The importance of patient, physician and visit characteristics","volume":"25","author":"Wilson","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0050","series-title":"Perspectiva de g\u00e9nero en las gu\u00edas de pr\u00e1ctica cl\u00ednica","author":"Rico","year":"2009"},{"key":"10.1016\/j.eimc.2013.04.002_bib0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.DBP.0000267570.87564.cd","article-title":"Disclosure of an HIV diagnosis to children: History, current research, and future directions","volume":"28","author":"Wiener","year":"2007","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0060","unstructured":"Gu\u00eda de pr\u00e1ctica cl\u00ednica para el abordaje integral del adolescente con infecci\u00f3n por el VIH. Ministerio de Sanidad y Pol\u00edtica social [consultado 18 Feb 2011]. Disponible en: http:\/\/www.mspsi.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/docs\/GPC_ ADOLESCENTES_VIH_PNS_MSC_def.pdf"},{"key":"10.1016\/j.eimc.2013.04.002_bib0065","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/INF.0b013e3181d770c4","article-title":"Longitudinal changes in carotid intima-media thickness and cardiovascular risk factors in human immunodeficiency virus-infected children and young adults compared with healthy controls","volume":"29","author":"Ross","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2013.04.002_bib0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/QAD.0b013e328336095d","article-title":"Total body and spinal bone mineral density across tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045","volume":"24","author":"Jacobson","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.04.002_bib0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3945\/ajcn.111.024786","article-title":"Effect of supplementation with cholecalciferol and calcium on 2-y bone mas accrual in HIV-infected children and adolescents: A randomized clinical trial","volume":"95","author":"Arpadi","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/QAI.0b013e3181f0ccb6","article-title":"Sexual transmission risk behavior of adolescents with HIV acquired perinatally or through risky behaviors","volume":"55","author":"Koenig","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0085","unstructured":"Recomendaciones para el seguimiento de la infecci\u00f3n por el VIH con relaci\u00f3n a la reproducci\u00f3n, el embarazo y la prevenci\u00f3n de la transmisi\u00f3n vertical. Secretar\u00eda del Plan Nacional sobre el Sida (SPNS), Grupo de Estudio del Sida (GeSida), Sociedad Espa\u00f1ola del Ginecolog\u00eda y Obstetricia (SEGO) y Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (AEP). Ministerio de Sanidad y Consumo. Madrid, 2007."},{"key":"10.1016\/j.eimc.2013.04.002_bib0090","unstructured":"Sociedad Espa\u00f1ola de Obstetricia y Ginecolog\u00eda (SEGO). Protocolos asistenciales en Obstetricia y Ginecolog\u00eda. Control prenatal del embarazo normal (julio 2010). Disponible en: http:\/\/www.prosego.com\/docs\/protocolos\/PDF_Control_prenatal_embarazo.pdf [consultado 12 Nov 2012]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0095","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/605292","article-title":"Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"49","author":"Aberg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.04.002_bib0100","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. May 24, 2012; p. 1\u2013117. Disponible en http:\/\/aidsinfo.nih.gov\/ContentFiles\/PerinatalGL.pdf [consultado 12 Jun 2012]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0105","unstructured":"Panel de Expertos de GeSIDA; Plan Nacional sobre el Sida. Documento de consenso respecto al tratamiento antirretroviral en adultos con infecci\u00f3n por el VIH. Enero de 2013. Accesible en: http:\/\/www.msssi.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/publicaciones\/profSanitarios\/docTARGesidaPNS2013Def.pdf [consultado 6 Feb 2013]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.GME.0000141981.88782.38","article-title":"Menopause symptoms in HIV-infected and drug-using women","volume":"12","author":"Miller","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.eimc.2013.04.002_bib0115","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM200103083441003","article-title":"Initial plasma HIV-1 RNA levels and progression to AIDS in women and men","volume":"344","author":"Sterling","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.04.002_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00126334-200209010-00002","article-title":"Gender difference in HIV RNA levels: A meta-analysis of published studies","volume":"31","author":"Napravnik","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0125","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/bmj.309.6968.1537","article-title":"HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study","volume":"309","author":"Cozzi Lepri","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.eimc.2013.04.002_bib0130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.aids.0000163934.22273.06","article-title":"Gender differences in clinical progression of HIV-1 infected individuals during long-term highly active antiretroviral therapy","volume":"19","author":"Nicastri","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.04.002_bib0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00042560-200202010-00015","article-title":"Gender and clinical outcomes after starting highly active antiretroviral treatment: A cohort study","volume":"29","author":"Moore","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0140","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2013.04.002_bib0145","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2003.01.096","article-title":"Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus infected patients","volume":"21","author":"Herida","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eimc.2013.04.002_bib0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","article-title":"A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals","volume":"52","author":"Shiels","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0155","unstructured":"Robinson WR. Preinvasive and invasive cervical neoplasia in HIV-infected women. En: UpToDate 2010. Disponible en: http:\/\/www.uptodate.com [consultado 12 Feb 2012]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0160","doi-asserted-by":"crossref","first-page":"e14349","DOI":"10.1371\/journal.pone.0014349","article-title":"HIV tropism and decreased risk of breast cancer","volume":"12","author":"Hessol","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.eimc.2013.04.002_bib0165","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1128\/AAC.01000-08","article-title":"Steady-s phamacokinetics of abacavir in plasma and intracellular carbovir thriphospate following administration of abacavir at 600 milligrams once dialy and 30 milligrams twice dialy in human immunodeficiency virus-infected subjects","volume":"53","author":"Moyle","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.04.002_bib0170","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1128\/AAC.01064-08","article-title":"Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): Investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir","volume":"53","author":"Pruvost","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.04.002_bib0175","series-title":"Program and abstracts of the 4th International Workshop on Clinical Pharmacology of HIV Therapy","article-title":"Gender differences in nevirapine pharmacokinetics, factor or fiction","author":"La Porte","year":"2003"},{"key":"10.1016\/j.eimc.2013.04.002_bib0180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2125.2005.02536.x","article-title":"Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: The effect of gender, race, and CYP2B6 polymorphism","volume":"61","author":"Burger","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.eimc.2013.04.002_bib0185","unstructured":"Kakuda TN, Sch\u00f6ler-Gy\u00fcre M, Peeters M, Corbett C, De Smedt G, Woodfall BJ, et al. Pharmacokinetics of etravirine are not affected by sex, age, race, treatment duration or use of enfuvirtide in HIV-1 infected patients. AIDS 2008-XVII International AIDS Conference. Abstract no. TUPE0082."},{"key":"10.1016\/j.eimc.2013.04.002_bib0190","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/0091270010388650","article-title":"Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men","volume":"51","author":"Umeh","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.eimc.2013.04.002_bib0195","series-title":"Presented at the 9th International Workshop on Clinical Pharmacology of HIV (IWCPHIV)","article-title":"Cocktail study to investigate the in-vivo drug interaction potential of darunavir coadministered with low-dose ritonavir (DRV\/r; RTV) on cytochrome P450 enzymes 2D6, 2C9 and 2C19","author":"Sekar","year":"2008"},{"key":"10.1016\/j.eimc.2013.04.002_bib0200","series-title":"11th International Workshop on Clinical Pharmacology of HIV Therapy (IWCPHIV)","article-title":"Intrinsic\/extrinsic covariates and darunavir pharmacokinetics in treatment-experienced patients in grace (gender, race and clinical experience)","author":"Kakuda","year":"2010"},{"key":"10.1016\/j.eimc.2013.04.002_bib0205","series-title":"1st International workshop on HIV and women from a adolescence through menopause","article-title":"Efficacy, safety and tolerability of Lopinavir\/r) in HIV-infected women: results of a meta-Analysis of 7 prospective, randomized clinical trials (RCTs) through 48 weeks","author":"Hermes","year":"2011"},{"key":"10.1016\/j.eimc.2013.04.002_bib0210","series-title":"Programm and abstracts of the 17th international AIDS Conference","article-title":"Impact of gender on response to lopinavir\/ritonavir (LPV\/r) tablets dosed QD or BID administered with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) in antiretroviral (ARV) na\u00efve subjects: results from study M05-730","author":"Da Silva","year":"2008"},{"key":"10.1016\/j.eimc.2013.04.002_bib0215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/dkq457","article-title":"Comparative gender analysis of the efficacy and safety of atazanavir\/ritonavir and lopinavir\/ritonavir at 96 weeks in the CASTLE study","volume":"66","author":"Squires","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2013.04.002_bib0220","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(07)60497-8","article-title":"Efficacy and safety of darunavir-ritonavir at week 48 in treatment experienced patients with HIV-1 infection in POWER 1 and 2: A pooled subgroup analysis of data from two randomized trials","volume":"369","author":"Clotet","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.04.002_bib0225","series-title":"Poster presented at the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention","article-title":"ARTEMIS: Week 96 safety and efficacy of darunavir\/r by gender, age and race","author":"Fourie","year":"2009"},{"key":"10.1016\/j.eimc.2013.04.002_bib0230","series-title":"Program and abstracts of the 18th Conference on Retroviruses and Opportunistic Infections","article-title":"Efficacy and safety of EFV with either co-formulated 3TC\/ZDV or FTC\/TDF for initial treatment of HIV-1-infected men and women in diverse multinational settings: ACTG PEARLS Study","author":"Campbell","year":"2011"},{"key":"10.1016\/j.eimc.2013.04.002_bib0235","series-title":"Program and abstracts of the 18th Conference on Retroviruses and Opportunistic Infections","article-title":"Association of Race\/Ethnicity and Sex on Outcomes in ACTG Study A5202","author":"Smith","year":"2011"},{"key":"10.1016\/j.eimc.2013.04.002_bib0240","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1089\/apc.2011.0278","article-title":"Meta-analysis of gender differences inefficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008)","volume":"26","author":"Soon","year":"2012","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.eimc.2013.04.002_bib0245","unstructured":"Kwakwa H, Spencer D, Evans C, Garner W, Walker I, Temme L. Gender differences in virologic outcomes in a meta-analysis of randomized controlled clinical trials in HIV-1 infected patients on antiretroviral therapy-\u00abwomen 28% less likely to achieve <50 cp\/ml. XIX IAC, july 22-27, 2012. Washington DC. Poster THPE041\u00bb."},{"key":"10.1016\/j.eimc.2013.04.002_bib0250","article-title":"Efficacy and use of PI vs EFV in treatment naives HIV+ men and women","author":"Patel","year":"2012","journal-title":"ICAAC"},{"key":"10.1016\/j.eimc.2013.04.002_bib0255","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMoa074609","article-title":"Class-sparing regimens for initial treatment of HIV-1 infection","volume":"358","author":"Riddler","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.eimc.2013.04.002_bib0260","unstructured":"Squires K, Bekker L, Eron J, Cheng B, Rockstroh J, Marquez F, et al. Safety, tolerability and efficacy of raltegravir in a diverse cohort of HIV-infected patients (pts): 48-week results from the REALMRK study. ICAAC 2011. 17-20 september 2011. Chicago. Abstract n.o H2-789."},{"key":"10.1016\/j.eimc.2013.04.002_bib0265","unstructured":"Hodder S, Martorell C, Feinberg J, Kumar P, Walmsley S et al. Effects of adherence and baseline viral load on virologic response, with resistance dyslipidemia\/lipodystrophy and bone mineral density analyses, among women compared to men in the phase III week 96 ECHO and THRIVE trials. IDSA San Diego 17-21 oct 2012. Poster 1352."},{"key":"10.1016\/j.eimc.2013.04.002_bib0270","article-title":"Gender stratification analysis of HIV-1 infected patients receiving atazanavir compared to ATV\/ritonavir each in combination with abacavair\/lamivudine after initial suppression with ABC\/3TC+ATV\/RTV thorugh 144 weeks on therapy","author":"Squires","year":"2012","journal-title":"ICAAC"},{"key":"10.1016\/j.eimc.2013.04.002_bib0275","first-page":"114","article-title":"Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-na\u00efve patients","volume":"11","author":"Cicconi","year":"2009","journal-title":"HIV Med"},{"key":"10.1016\/j.eimc.2013.04.002_bib0280","series-title":"14th Conference on Retroviruses and Opportunistic Infections","article-title":"Severe hyperlactatemia complicating ART with stavudine first-line therapy in South Africa: Incidence, risk factors and outcomes","author":"Osler","year":"2007"},{"key":"10.1016\/j.eimc.2013.04.002_bib0285","article-title":"Experience using AZT and d4T in TAHOD patients: treatment duration and AZT-related anemia. 14th Conference on Retroviruses and Opportunistic Infections","author":"Huffam","year":"2007","journal-title":"Los Angeles"},{"key":"10.1016\/j.eimc.2013.04.002_bib0290","unstructured":"Ficha t\u00e9cnica de Viramune [consultado 4 Mar 2011]. Disponible en: http:\/\/www.ema.europa.eu\/"},{"key":"10.1016\/j.eimc.2013.04.002_bib0295","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/QAI.0b013e31813e5e20","article-title":"Response to efavirenz containing regimens in previously antiretroviral na\u00efve HIV-positive patients: The role of gender","volume":"46","author":"Smith","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0300","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm.2004","article-title":"Sex differences in the toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1","volume":"15","author":"Meier","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.eimc.2013.04.002_bib0305","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV-infected individuals","volume":"33","author":"Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0310","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QAI.0b013e31817af461","article-title":"Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV study","volume":"48","author":"Sobieszczyk","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0315","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7326\/0003-4819-153-6-201009210-00002","article-title":"Sex-based outcomes of darunavir-ritonavir therapy. A single-group trial","volume":"153","author":"Currier","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2013.04.002_bib0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/apc.2010.0386","article-title":"Effects of darunavir\/ritonavir based therapy on metabolic and anthropometric parameters in women and men over 48 weeks","volume":"25","author":"Currier","year":"2011","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.eimc.2013.04.002_bib0325","series-title":"17th CROI","article-title":"Fracture rates are not increased in younger HIV+ women","author":"Yin","year":"2010"},{"key":"10.1016\/j.eimc.2013.04.002_bib0330","series-title":"16th CROI","article-title":"Determinants of low bone density in postmenopausal HIV+ women","author":"Yin","year":"2009"},{"key":"10.1016\/j.eimc.2013.04.002_bib0335","unstructured":"Yin MT, Cremers S, Lu D, Shane E, Gao W, McMahon D, et al. Short term bone loss in HIV infected premenopausal women. 15th CROI. Boston, Massachusetts, Abstract 965."},{"issue":"Suppl 1","key":"10.1016\/j.eimc.2013.04.002_bib0340","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.aids.0000363778.58203.b6","article-title":"Safety of hormonal and intrauterine methods of contraception for women with HIV\/AIDS: A systematic review","volume":"23","author":"Curtis","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.04.002_bib0345","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/humupd\/dmn049","article-title":"Contraception and HIV infection in women","volume":"15","author":"Heikinheimo","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.eimc.2013.04.002_bib0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/13625180701829952","article-title":"Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives","volume":"13","author":"El-Ibiary","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.eimc.2013.04.002_bib0355","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/aje\/kwi116","article-title":"Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy","volume":"161","author":"Chu","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eimc.2013.04.002_bib0360","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00126334-200204150-00007","article-title":"Pharmacokinetic interaction between nevirapine and ethinyl estradiol\/norethindrone when administered concurrently to HIV-infected women","volume":"29","author":"Mildvan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.04.002_bib0365","unstructured":"Anderson MS, Wenning LA, Moreau A, Kost IT, Bieberdorf FA, Stone JA, et al. Effect of Raltegravir (RAL) on the Pharmacokinetics (PK) of Oral Contraceptives ICAAC; 2007 September, 17-20; Chicago. 2007. Presentation Number: A-1425."},{"key":"10.1016\/j.eimc.2013.04.002_bib0370","unstructured":"Zhang J, Chung E, Eley T, Yones C, Persson A, Xu X, et al. Effect of Atazanavir\/Ritonavir on the Pharmacokinetics of Ethinyl Estradiol and 17-Deacetyl Norgestimate in Healthy Female Subjects Keywords: atazanavir, drug-drug interaction, HIV ICAAC; 2007 September, 17-20, 2007; Chicago. 2007. Presentation Number: A-1415."},{"key":"10.1016\/j.eimc.2013.04.002_bib0375","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.fertnstert.2007.07.1348","article-title":"Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy","volume":"90","author":"Nanda","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eimc.2013.04.002_bib0380","unstructured":"Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States (May 24, 2012) [consultado 14 Dic 2012]. Disponible en: http:\/\/aidsinfo.nih.gov\/ContentFiles\/PerinatalGL.pdf"},{"key":"10.1016\/j.eimc.2013.04.002_bib0385","unstructured":"Polo R, Iribarren JA, Gonzalez Tom\u00e9 I, Mu\u00f1oz G\u00e1lligo E (coordinadores). Recomendaciones de la Secretar\u00eda del PNS, el GeSIDA, la SEGO y la AEP para el seguimiento de la infecci\u00f3n por el VIH con relaci\u00f3n a la reproducci\u00f3n, el embarazo y la prevenci\u00f3n de la transmisi\u00f3n vertical (marzo 2013). Disponible en: http:\/\/www.msssi.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/publicaciones\/profSanitarios\/DocEmbarazoMarzo2013.pdf [consultado 8 Mar 2013]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0390","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/sti.2004.009266","article-title":"Sexual dysfunction in women with HIV","volume":"81","author":"Goldmeier","year":"2005","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.eimc.2013.04.002_bib0395","first-page":"1","article-title":"Loneliness and HIV-related stigma explain depression among older HIV-positive adults","volume":"16","author":"Grov","year":"2010","journal-title":"AIDS Care"},{"key":"10.1016\/j.eimc.2013.04.002_bib0400","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00737-009-0094-1","article-title":"Depression in women living with HIV: Clinical and psychosocial correlates","volume":"13","author":"Mello","year":"2010","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.eimc.2013.04.002_bib0405","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00737-010-0158-2","article-title":"Correlates of HIV stigma in HIV-positive women","volume":"13","author":"Wagner","year":"2010","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.eimc.2013.04.002_bib0410","unstructured":"Naciones Unidas (1993). Declaraci\u00f3n sobre la eliminaci\u00f3n de la violencia contra la mujer. Asamblea General. 85.a sesi\u00f3n plenaria. 20 de Dic de 1993. Disponible en: http:\/\/daccess-ddsny.un.org\/doc\/UNDOC\/GEN\/N94\/095\/08\/PDF\/N9409508.pdf [consultado 7 Abr 2011]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0415","unstructured":"ONUSIDA (2010). La agenda para la acci\u00f3n acelerada de los pa\u00edses para abordar la problem\u00e1tica de las mujeres, las ni\u00f1as, la igualdad de g\u00e9nero y el VIH. Disponible en: http:\/\/data.unaids.org\/pub\/Report\/2010\/jc1794_action_framework_gender_equalit y_es.pdf [consultado 7 Abr 2011]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0420","unstructured":"World Health Organization (2009). Women and health: today's evidence tomorrow's agenda. Disponible en: http:\/\/whqlibdoc.who.int\/publications\/2009\/9789241563857_eng.pdf [consultado 7 Abr 2011]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0425","unstructured":"Organizaci\u00f3n Panamericana de la Salud, Organizaci\u00f3n Mundial de la Salud, 2003. Informe mundial sobre la violencia y la salud. Disponible en: http:\/\/www.paho.org\/spanish\/dd\/pub\/violencia_2003.htm [consultado 27 Mar 2011]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0430","unstructured":"Ministerio de Sanidad y Consumo (2008). Recomendaciones de la SPNS\/GESIDA\/AEP\/CEEISCAT sobre la profilaxis post-exposici\u00f3n frente al VIH, VHB y VHC en adultos y ni\u00f1os. Disponible en: http:\/\/www.msps.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/docs\/PPE_14-01-08.pdf [consultado 26 Nov 2012]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0435","unstructured":"Organizaci\u00f3n Mundial de la Salud (2001). Violence against women and HIV\/AIDS: setting the research agenda. Organizaci\u00f3n Mundial de la Salud, 2001. Disponible en: http:\/\/whqlibdoc.who.int\/hq\/2001\/WHO_FCH_GWH_01.08.pdf [consultado 27 Mar 2011]."},{"key":"10.1016\/j.eimc.2013.04.002_bib0440","article-title":"Domestic violence screening: Prevalence and outcomes in Canadian HIV population","author":"Siemieniud","year":"2010","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.eimc.2013.04.002_bib0445","unstructured":"World Health Organization. International Classification of Diseases (CIE-10) [consultado Jun 2011]. Disponible en: http:\/\/apps.who.int\/classifications\/apps\/icd\/icd10online\/"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X13001171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X13001171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T21:47:51Z","timestamp":1645652871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X13001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0213005X13001171"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2013.04.002","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}